AstraZeneca: clinical trials resume for Covid-19 vaccine
(CercleFinance.com) - Clinical trials of AstraZeneca's coronavirus vaccine, in collaboration with Oxford University have resumed in the UK, after the Medicines Health Regulatory Authority (MHRA) confirmed that it was safe.
The British committee has completed its investigations and has recommended to the MHRA that it is safe to resume testing in the UK.
"AstraZeneca is committed to the safety of trial participants and the highest standards of conduct in clinical trials," the company said.
Copyright (c) 2020 CercleFinance.com. All rights reserved.
The British committee has completed its investigations and has recommended to the MHRA that it is safe to resume testing in the UK.
"AstraZeneca is committed to the safety of trial participants and the highest standards of conduct in clinical trials," the company said.
Copyright (c) 2020 CercleFinance.com. All rights reserved.